Introduction
============

Colorectal cancer (CRC) is a kind of complicated disease that severely affects human health worldwide. According to a report conducted by Siegel et al[@b1-ott-8-3003] in 2015, \~132,700 individuals will be diagnosed as new CRC cases and 49,700 individuals will die due to the disease in the USA. Meanwhile, 2015 People's Republic of China cancer report showed that there were 310,244 newly diagnosed CRC patients and 149,722 dead CRC cases in 2011.[@b2-ott-8-3003] Although there is a rapid advance in the research of CRC initiation and progression mechanisms, the cause of a large proportion of the cases remains unclear.[@b3-ott-8-3003],[@b4-ott-8-3003] It is well known that the disease is initiated by an intense cross talk of genetic and environmental factors.[@b5-ott-8-3003] Emerging studies showed that genetic variations of related genes were significantly associated with risk and clinical outcome of the disease.[@b6-ott-8-3003]--[@b8-ott-8-3003]

MicroRNA-27a (miR-27a) is an oncogene in malignancies including CRC.[@b9-ott-8-3003] It is located in 19p13.13 containing an exon and the transcript is a 22 nucleotide noncoding RNA. Overexpression of hsa-miR-27a was examined in laryngeal carcinoma, osteosarcoma, hepatocellular carcinoma, CRC, and many kinds of cell lines, such as HepG2, Bel-7402, Bel-7404, SW480, and HT29 cell lines.[@b10-ott-8-3003]--[@b14-ott-8-3003] Moreover, it was involved in cell proliferation, cell cycle transition and apoptosis, colony formation, migration, and metastasis in cancer cell line.[@b11-ott-8-3003],[@b12-ott-8-3003] Additionally, it mediated a poor response to chemotherapy in esophageal squamous cell carcinoma, leukemia, lung adenocarcinoma, gastric cancer, and SW480 cell lines.[@b14-ott-8-3003]--[@b17-ott-8-3003]

Rs895819 is a common single nucleotide polymorphism (SNP) locating in pre-miR-27a. Alternation from A to G of the locus may contribute to its abnormal secondary structure and aberrant expression of hsa-miRNA-27a, leading to dysfunction of hsa-miRNA-27a or aberrant expression of its targeted gene. Some case--control studies have been carried out to investigate the association between the locus and risk of cancer.[@b18-ott-8-3003]--[@b21-ott-8-3003] Xiong et al[@b21-ott-8-3003] reported that allele A and genotypes AG and AA of the locus were associated with a decreased risk of cervical cancer. Whereas studies conducted by Ma et al[@b20-ott-8-3003] and Xu et al[@b22-ott-8-3003] indicated that there was a positive association between the locus and susceptibility to nonsmall-cell lung cancer and digestive tract cancer, respectively. So we hypothesize that rs895819 within pre-miR-27a may be involved in the carcinogenesis of CRC.

Hence, we investigated allele and genotype frequencies of the locus in 412 I--III stage CRC cases and 412 age- and sex-matched healthy individuals using Taqman-polymerase chain reaction (PCR) to explore the possible association between them in north Chinese population.

Materials and methods
=====================

A total of 412 clinical pathological confirmed CRC patients and 412 age- and sex-matched healthy checking-up participants, from May 2009 to December 2014 in Union Medical Center of Tianjin, Nankai University Affiliated Hospital, were included in our study. All enrolled individuals were Chinese Han population, which consisted of \>95% of the population in the People's Republic of China. All controls were free of cancer clinical symptom, and serum CEA was \<5 μg/L. Human genomic DNA of each participant was extracted from 200 μL ethylenediaminetetraacetic acid-anticoagulated peripheral blood samples using Qiagen human genomic DNA isolation kit (Qiagen NV, Venlo, Netherlands) according to the manufacturer's protocol. Ultraviolet spectrophotometer (Eppendorf, Hamburg, Germany) was used to detect DNA concentration and purity of each sample, and A260/A280 ratio should be within the interval of 1.8--2.0. Genotype of rs895819 was detected by Taqman discrimination assay using ABI7300 fluorescence quantitative PCR system (Thermo Fisher Scientific, Waltham, MA, USA). The detection was performed in a total volume of 5 μL that contained 100 ng genomic DNA temple, 2.5 μL 2× TaqMan PCR MasterMix, and 2.5 μL 20× SNP Assay (including primer and FAM/VIC: Carboxyfluorescein/Victoria probe). rs895819 primer and probe sequences and reaction conditions were used according to the description by Xu et al[@b23-ott-8-3003] and 5% PCR products were randomly selected to DNA sequencing. All written informed consents were signed by all included individuals, and the study was approved by the ethical committee of Union Medical Center of Tianjin, Nankai University Affiliated Hospital.

We directly counted the allele and genotype distributions of rs895819 in two groups. Hardy--Weinberg equilibrium (HWE) software (<http://www.oege.org/software/hwe-mr-calc.shtml>) was used to evaluate whether the genotypes of the locus fit for HWE in controls. Personal *χ*^2^-test was used to examine the allele or genotype distribution difference in the two groups. Odds ratio (OR) and 95% confidence interval (95% CI) were calculated to evaluate the strength between the locus and risk of CRC. *P*\<0.05 was considered as a significant difference in all statistics. All the data analyses were conducted using SPSS 19.0 statistical software (IBM Corporation, Armonk, NY, USA).

Results
=======

The baseline characteristics of the two groups were shown in [Table 1](#t1-ott-8-3003){ref-type="table"}. However, no significant difference was observed in terms of age, sex, smoking, and drinking between the two groups. The details of the rs895819 allele and genotype frequencies in the two groups were listed in [Table 2](#t2-ott-8-3003){ref-type="table"}. The locus genotype frequencies of AA, AG, and GG in the controls were 49.8%, 40.2%, and 9.9%, respectively. The frequency distribution was similar with the report in dbSNP database (<http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=895819>) in Chinese Han population, and the controls' genotype distribution was consistent with HWE (*χ*^2^=0.742, *P*=0.388).

The frequencies of genotypes AA, AG, and GG and alleles A and G of rs895819 were 48.3%, 34.7%, 17.0%, 65.7%, and 34.3% in cases and 49.8%, 40.2%, 9.9%, 69.9%, and 30.1% in controls, respectively. There was no significant genotype frequency difference in comparison of AG vs AA (34.7% vs 40.2%, *P*=0.43, adjusted OR =0.871, 95% CI =0.676--1.131) or allele G vs A (34.1% vs 30.1%, *P*=0.065, adjusted OR =1.247, 95% CI =0.913--1.652), suggesting that genotype AG and allele G of the locus were not associated with CRC. There was no significant frequency difference in dominant model (AG/GG vs AA: 51.7% vs 51.2%, *P*=0.676, adjusted OR =1.210, 95% CI =0.754--1.524) or overdominant model (AA/GG vs AG: 65.3% vs 59.8%, *P*=0.098, adjusted OR =0.810, 95% CI =0.632--1.232). Whereas significant frequency differences were examined in comparison of GG vs AA (17.0% vs 9.9%, *P*=0.01, adjusted OR =1.541, 95% CI =1.110--2.239) and in recessive model (17.0% vs 9.9%, *P*=0.003, adjusted OR =1.855, 95% CI =1.221--2.786 for genotype GG vs AA/GA).

The relationship between clinical pathological characteristics and rs895819 was shown in [Table 3](#t3-ott-8-3003){ref-type="table"}. As shown from [Table 3](#t3-ott-8-3003){ref-type="table"}, there was no significant difference of rs895819 genotype and allele frequency distributions in the subgroups of clinical pathological characteristics, such as CRC location, differentiation, invasion, and node metastasis. However, genotypes AG (*P*\<0.001) and GG (*P*\<0.001) and allele G (*P*=0.001) of the locus were significantly associated with TNM-III stage in our study, respectively.

Discussion
==========

miRNA is a group of noncoding RNA that plays a powerful role both in organ growth and development, cell proliferation, differentiation, and apoptosis and as a tumor oncogene or suppressor in cancer.[@b24-ott-8-3003]--[@b27-ott-8-3003] Although it only accounts for a small proportion of human genome, it can regulate approximately one-third of human genes.[@b28-ott-8-3003] Genetic variations of miRNA would affect its maturation and its binding capacity with mRNA-3′-untranslated region of the targeted gene, leading to dysfunctional regulation of its targeted gene. Recently, SNPs within miRNA were reported to be significantly associated with initiation, progression, and drug response in cancer.[@b29-ott-8-3003]--[@b31-ott-8-3003] rs895819 is located in the terminal loop of pre-miRNA-27a; it would affect the secondary structure of pre-miR-27a and result in its abnormal expression of hsa-miR-27a. So we speculate that rs895819 within pre-miR-27a may be involved in CRC carcinogenesis.

In this study, our results showed that genotype GG frequency of the locus was significantly higher in cases than controls, suggesting that genotype GG of the locus was positively associated with CRC risk and it might be a genetic susceptible factor for CRC. Moreover, genotypes AG and GG and allele G of the locus were significantly associated with TNM-III stage, indicating that genotypes AG and GG and allele G were associated with CRC progression. The result of our study was also consistent with the results of recent studies conducted by Cao et al[@b32-ott-8-3003] and Wang et al[@b33-ott-8-3003] in Chinese population, but our study was more powerful to support a positive association between the locus and CRC in Chinese population. Wang et al reported that genotype GG and allele G were associated with an increased risk of metastasis; however, our study showed a positive association between allele G and allele G carrier (genotypes AG and GG) and invasion depth. However, Hezova et al[@b34-ott-8-3003] and Kupcinskas et al[@b35-ott-8-3003] reported no association between them in European Caucasian population. The following reasons may account for this phenomenon. First of all, different genetic background may be one of the most important causes leading to the contradictory results. Second, *miR-27a* have been reported as an oncogene in many kinds of cancer, including CRC;[@b9-ott-8-3003],[@b10-ott-8-3003],[@b36-ott-8-3003] overexpression of hsa-miR-27a was detected both in SW480 and HT29 cell lines and in CRC biopsy;[@b9-ott-8-3003],[@b14-ott-8-3003] genotypes of rs895819 were significantly associated with hsa-miR-27a expression in CRC biopsy,[@b32-ott-8-3003] suggesting that rs895819 within hsa-miR-27a was involved in CRC pathogenesis, and the locus could affect its expression. Third, higher hsa-miR-27a leads to lower expression of targeted *PPAR-γ*, *PLK2*, and *PI3K* genes,[@b10-ott-8-3003],[@b12-ott-8-3003],[@b37-ott-8-3003] contributing to the improvement of cell viability and colony formation and inhibition of the late apoptosis of CRC cell line.

Conclusion
==========

In conclusion, our findings indicated that rs895819 within pre-miR-27a was involved in colorectal carcinogenesis and progression, genotype GG of the locus might be a susceptible factor for CRC, and allele G and allele G carrier (genotypes AG and GG) could predict CRC progression in north Chinese Han population.
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###### 

Baseline characteristics of the cases and controls

  Variables                     Cases (412)   Percentage   Controls (412)   Percentage   *P*-value
  ----------------------------- ------------- ------------ ---------------- ------------ -----------
  Age (years, M + SD)           61.2±10.5                  61.2±10.5                     \>0.05
  Sex                                                                                    
   Male                         293           71.10        293              58.50        \>0.05
   Female                       119           28.90        119              41.50        
  Smoking                                                                                
   Yes                          105           25.50        89               21.60        0.954
   No                           307           74.50        333              78.40        
  Drinking                                                                               
   Yes                          113           27.40        101              24.51        0.965
   No                           301           72.60        311              75.49        
  Location                                                                               
   Right colon                  210           51.00                                      
   Left colon                   97            23.54                                      
   Rectum                       105           25.46                                      
  Differentiation                                                                        
   High/moderate                332           80.58                                      
   Poor/undifferentiated        80            19.41                                      
  Tumor-Node-Metastasis (TNM)                                                            
   I/II                         287           69.66                                      
   III                          125           30.34                                      
  Cancer invasion                                                                        
   T1/T2                        90            21.84                                      
   T3/T4                        322           78.16                                      
  Node metastasis                                                                        
   N0/N1                        89            21.60                                      
   N2/N3                        323           78.40                                      

**Abbreviations:** M, mean; SD, standard deviation.

###### 

Genotype and allele distributions of rs895819 in two groups

  Model          Genotype and allele   Cases         Controls      *P*-value              OR and 95% CI          Adjusted OR and 95% CI[a](#tfn2-ott-8-3003){ref-type="table-fn"}
  -------------- --------------------- ------------- ------------- ---------------------- ---------------------- ------------------------------------------------------------------
  Codominant     AA                    199 (48.3%)   205 (49.8%)                                                 
  AG             143 (34.7%)           166 (40.2%)   0.43          0.901 (0.670--1.214)   0.871 (0.676--1.131)   
  GG             70 (17.0%)            41 (9.9%)     0.01          1.523 (1.124--2.231)   1.541 (1.110--2.239)   
  Dominant       AA                    199 (48.3%)   205 (49.8%)                                                 
  AG/GG          213 (51.7%)           207 (50.2%)   0.676         1.231 (0.741--1.431)   1.210 (0.754--1.524)   
  Recessive      AA/AG                 342 (83.0%)   371 (90.1%)                                                 
  GG             70 (17.0%)            41 (9.9%)     0.003         1.852 (1.226--2.798)   1.855 (1.221--2.786)   
  Overdominant   AG                    143 (34.7%)   166 (40.2%)                                                 
  AA/GG          269 (65.3%)           246 (59.8%)   0.098         0.802 (0.622--1.221)   0.810 (0.632--1.232)   
  Allele         Allele A              541 (65.7%)   576 (69.9%)                                                 
  Allele G       283 (34.3%)           248 (30.1%)   0.065         1.213 (0.947--1.522)   1.247 (0.913--1.652)   

**Note:**

OR and 95% CI were adjusted by sex, age, smoking, and drinking.

**Abbreviations:** OR, odds ratio; CI, confidence interval.

###### 

Association between rs895819 and clinical pathological characteristics in case group

  Variables                           Genotype   *P*-value   Allele   *P*-value                         
  ----------------------------------- ---------- ----------- -------- ----------- --------- ----- ----- -------
  Location                                                                                              
   Right colon                        106        70          34                             282   138   
   Left colon                         46         32          19       0.851       0.451     124   70    0.432
   Rectum                             47         41          17       0.29        0.727     135   75    0.475
  Differentiation                                                                                       
   High/moderate                      161        113         58                             435   229   
   Poor/undifferentiated              38         30          20       0.667       0.228     106   70    0.193
  Tumor-Node-Metastasis (TNM) stage                                                                     
   I/II                               134        129         24                             397   177   
   III                                65         14          46       \<0.001     \<0.001   144   106   0.001
  Cancer invasion                                                                                       
   T1/T2                              42         28          20                             112   68    
   T3/T4                              157        115         50       0.73        0.202     429   215   0.273
  Node metastasis                                                                                       
   N0/N1                              49         25          15                             123   55    
   N2/N3                              150        113         55       0.156       0.589     413   223   0.3

**Notes:** \[1\]: genotype AG vs AA; \[2\]: genotype GG vs AA.
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